We first examined how normal human breast epithelial cells from four different reduction mammoplasties responded to a breast cancer culture medium containing the essential components of Neuregulin-1 and the ROCK inhibitor Y-27632 [2]. The gene discussed is NRG1; the disease is breast cancer.